Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model. (Q42189720)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

Mycobacterium tuberculosis

27 January 2020

main subject

0 references

1 reference

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

V Balasubramanian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

S Solapure

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

S Gaonkar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

K N Mahesh Kumar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

R K Shandil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Abhijeet Deshpande

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Naveen Kumar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

K G Vishwas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Vijender Panduga

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Jitendar Reddy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

A Louie

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

G L Drusano

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

2 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

3054-3057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system

27 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

The search for synergy: a critical review from a response surface perspective.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3370723

29 May 2018

Identifiers

DOI

10.1128/AAC.06383-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22470118%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference